Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.
Bladé
J
J
Department of Haematology, Hospital Clinic, IDIBAPS, Barcelona, Spain.
Samson
D
D
Reece
D
D
Apperley
J
J
Björkstrand
B
B
Gahrton
G
G
Gertz
M
M
Giralt
S
S
Jagannath
S
S
Vesole
D
D
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D018450:Disease Progression; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D009101:Multiple Myeloma / Q000628:therapy*; D012008:Recurrence; D016896:Treatment Outcome
D000970:Antineoplastic Agents